Related Experiment Video
Updated: May 24, 2025

09:37
Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
9.6K
Rapid, Reliable, and Interpretable Copy Number Variant Curation Visualizations for Diagnostic Settings with SeeNV
Michael S Bradshaw1, Jishnu Raychaudhuri1, Lachlan Murphy1
1Department of Computer Science, University of Colorado Boulder, Boulder, Colorado.
The Journal of Molecular Diagnostics : JMD
|March 5, 2025
Summary
SeeNV is a new tool that helps researchers quickly and accurately check copy number variants (CNVs) found using whole-exome sequencing. This automation improves the reliability of genetic variant analysis in clinical diagnostics.
Area of Science:
- Genomics
- Bioinformatics
- Clinical Diagnostics
Background:
- Copy number variants (CNVs) are significant genomic alterations linked to various diseases.
- Accurate CNV identification is challenging with whole-exome sequencing (WES) due to technical noise.
- Manual curation of CNV calls is time-consuming and prone to errors.
Purpose of the Study:
- To introduce SeeNV, a command-line tool designed to streamline manual curation of CNVs.
- To improve the efficiency and accuracy of CNV assessment in clinical settings.
- To facilitate large-scale CNV analysis using WES data.
Main Methods:
- SeeNV generates static infographics for each CNV.
- Infographics include sample/cohort sequencing coverage and population frequency data.
- The tool was validated using publicly available WES and whole-genome sequencing data.
Main Results:
- SeeNV enables rapid CNV curation, averaging 4.3 seconds per call.
- Achieved high analytical sensitivity (0.95 recall) and good positive predictive value (0.74 precision).
- The tool aids in precise assessment of CNV calls.
Conclusions:
- SeeNV effectively addresses the challenges of manual CNV curation from WES data.
- The tool enhances the speed and reliability of CNV analysis in diagnostic laboratories.
- SeeNV is freely available, promoting wider adoption in genomic research and diagnostics.

